Clinical Diabetes 22:144-145, 2004
© American Diabetes Association ®, Inc., 2004
Case Study: Skin Infection in a Diabetic Patient Related to Contamination of an Insulin Bottle
Irma Gazeroglu, MD,
Michael Borenstein, MD, PhD and
Maria P. Solano, MD
| The first 20% of the full text of this article appears below. |
 |
Presentation
|
|---|
D.P. is a 59-year-old white Hispanic woman with a 12-year history of type 2
diabetes treated with a thiazolidindione and multiple daily injections of
insulin. She presented to the outpatient clinic with a 10-week history of
painful skin lesions on her abdomen that had been increasing in size. The
lesions developed at the site of insulin injections. She was injecting in the
abdomen, using a new needle each time. She had received a 14-day course of
levofloxacin 7 weeks before the clinic visit and had been instructed to change
the insulin bottles and to use her arms for injection. The skin lesions did
not seem to improve, but she did not developed new lesions. She denied fever
or other constitutional symptoms.
Her medical history was significant for severe asthma requiring chronic
oral steroids and hypertension. Her . . . [Full Text of this Article]
|
Questions
|
|---|
|
Commentary
|
|---|
|
Clinical Pearls
|
|---|
 CiteULike  Del.icio.us  Digg  Reddit  Technorati What's this?
Copyright © 2004 by the American Diabetes Association.
|
|
|
